Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis
Trial details
- Registry ID
- NCT05415137
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as ATYR1923; KRP-R120
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary SarcoidosisNCT05415137 | ATYR | Phase 3 | Completed | 2025-06-25Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |